Fund focus: TR raises $350m for China-heavy secondaries strategy
Having closed its fourth fund at the hard cap of $350 million, Asia secondaries specialist TR Capital expects to go deep into China fund restructurings, taking out renminbi investors onshore and offshore
China accounted for $4 in every $5 raised through private equity-backed IPOs in Asia last year, a level of dominance unmatched in nearly a decade. In 2011, mainland bourses were the preferred port of call....
More on Fundraising
Latest News
PE investors wary of inflation in 2022 - AVCJ Forum
Inflation is top of mind for Asia-focused private equity investors as they assess the various uncertainties facing the industry in 2022, the AVCJ Private Equity & Venture Forum heard.
Legend hits first close on healthcare fund, launches TMT vehicle
Legend Capital has reached a first close of $177 million on its third US dollar-denominated China healthcare fund. It is one of five vehicles the GP has in the market, including its recently launched ninth flagship technology, media, and telecom (TMT)...
Qiming leads $40m round for Allorion Therapeutics
China and US-based precision medicine company Allorion Therapeutics has raised a $40 million Series A round led by Qiming Venture Partners.
Japan space debris start-up Astroscale gets $109m Series F
Astroscale, a Japanese space tech start-up dedicated to cleaning up orbital debris, has raised $109 million in Series F funding from investors including London-listed Seraphim Space Investment Trust, Japan Growth Capital Investment, and Axa Life Insurance.